Scott Morrison

Mr. Morrison has served public and private companies in the life sciences industry since 1980. Mr. Morrison was a partner at Ernst & Young (EY) and was the U.S. Life Sciences Leader until his retirement in 2015. During his tenure at EY he worked on hundreds of public and private financings, M&A transactions, and corporate collaborations. Mr. Morrison serves on the Board of Directors and chairs the Audit Committee of Audentes, Inc. (through its sale to Astellas in January 2020), Corvus Pharmaceuticals, Global Blood Therapeutics (GBT) and Ideaya Biosciences. He also serves as a member of the Compensation Committee for GBT and Corvus and is a member of the GBT’s Commercial Committee. Mr. Morrison has also served as a director on several life sciences industry boards including the Biotechnology Innovation Organization (BIO) ECS board, the Bay Area Biosciences Board (now CLSA), the Life Sciences Foundation, and the Biotechnology Institute. Mr. Morrison was awarded the CLSA Pantheon 2016 Life Sciences Leadership Award. Mr. Morrison holds a B.S. in Business Administration from the Haas School at University of California, Berkeley and is a Certified Public Accountant (inactive).